1. Home
  2. AQST vs LX Comparison

AQST vs LX Comparison

Compare AQST & LX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • LX
  • Stock Information
  • Founded
  • AQST 2004
  • LX 2013
  • Country
  • AQST United States
  • LX China
  • Employees
  • AQST N/A
  • LX N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • LX Finance: Consumer Services
  • Sector
  • AQST Health Care
  • LX Finance
  • Exchange
  • AQST Nasdaq
  • LX Nasdaq
  • Market Cap
  • AQST 809.3M
  • LX 843.0M
  • IPO Year
  • AQST 2018
  • LX 2017
  • Fundamental
  • Price
  • AQST $6.99
  • LX $5.34
  • Analyst Decision
  • AQST Strong Buy
  • LX
  • Analyst Count
  • AQST 7
  • LX 0
  • Target Price
  • AQST $10.71
  • LX N/A
  • AVG Volume (30 Days)
  • AQST 3.6M
  • LX 2.4M
  • Earning Date
  • AQST 10-31-2025
  • LX 11-24-2025
  • Dividend Yield
  • AQST N/A
  • LX 7.31%
  • EPS Growth
  • AQST N/A
  • LX 86.38
  • EPS
  • AQST N/A
  • LX 1.28
  • Revenue
  • AQST $44,132,000.00
  • LX $1,956,013,429.00
  • Revenue This Year
  • AQST N/A
  • LX $6.40
  • Revenue Next Year
  • AQST $51.50
  • LX $17.75
  • P/E Ratio
  • AQST N/A
  • LX $4.09
  • Revenue Growth
  • AQST N/A
  • LX 0.80
  • 52 Week Low
  • AQST $2.12
  • LX $2.88
  • 52 Week High
  • AQST $7.55
  • LX $11.64
  • Technical
  • Relative Strength Index (RSI)
  • AQST 63.34
  • LX 47.52
  • Support Level
  • AQST $6.78
  • LX $4.93
  • Resistance Level
  • AQST $7.55
  • LX $5.13
  • Average True Range (ATR)
  • AQST 0.41
  • LX 0.24
  • MACD
  • AQST 0.04
  • LX 0.05
  • Stochastic Oscillator
  • AQST 71.13
  • LX 48.30

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About LX LexinFintech Holdings Ltd.

LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.

Share on Social Networks: